Navigation Links
CuraGen Announces Top-Line Phase II Results on Velafermin
Date:10/11/2007

- Conference call to be hosted today at 8:30 a.m. Eastern Time -

BRANFORD, Conn., Oct. 11 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that its Phase II dose-confirmatory clinical trial (CLN-12) evaluating a single dose of velafermin for the prevention of severe oral mucositis demonstrated that velafermin was safe and well-tolerated but did not meet its primary endpoint. Based on these results, the Company is discontinuing the development of velafermin, and will continue to focus its resources on belinostat, a Phase II histone deacetylase (HDAC) inhibitor for the treatment of solid tumors and hematologic malignancies, and CR011-vcMMAE, a Phase I/II antibody-drug conjugate for the treatment of metastatic melanoma.

"While we are disappointed that the primary endpoint was not met in this study, on behalf of everyone at CuraGen, I would like to thank all of the patients and investigators who took part in the velafermin development program," commented Timothy Shannon, President and Chief Executive Officer of CuraGen. "We continue to aggressively focus on our goal of advancing the belinostat and CR011-vcMMAE programs toward initiation of Phase III development in 2008, and we look forward to presenting updated clinical trial results on these programs in October at the AACR-NCI-EORTC conference, and in December at the ASH Annual Meeting."

CLN-12 was a randomized, double-blind, placebo-controlled study designed to assess a reduction in the incidence of severe Grade 3 or 4 oral mucositis in patients receiving high-dose chemotherapy followed by autologous bone marrow transplantation (BMT). The trial enrolled 390
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015 ... devices market? Which areas are going to grow at ... potential revenues to 2025, assessing data, trends, opportunities and ... tables, charts, and graphs. Discover the most lucrative areas ... new study lets you assess forecasted sales at overall ...
(Date:9/3/2015)... 3,  2015 About artificial organs ... which are implanted or integrated into individuals ... include artificial heart, kidney, pancreas, and cochlear ... polysulfone, and porous polypropylene), biologics, ceramics, and ... These organs are incorporated with different technologies ...
(Date:9/3/2015)... 2015  WellCare Health Plans, Inc. (NYSE: WCG ... vice president and chief financial officer, is scheduled to ... on Wednesday, September 9, 2015, at 9:25 a.m. Eastern ... In addition, a replay of the webcast will be ... the live broadcast and the replay will be available ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Global Artificial Organ Market 2015-2019 2
... heels of launching its enhanced Lilly for Better Health ... introduces the Lilly Health Channel on YouTube – ... employee and community outreach efforts, health innovation, Lilly programs and ... spotlight issues like the growing rate of diabetes ...
... SAN JOSE, Calif., Sept. 8, 2011 Sanmina-SCI ... manufacturing solutions company making some of the world,s ... today announced that its Kenosha, Wisconsin, facility has ... manufacturing. Achieving this certification recognizes Sanmina-SCI,s world-class manufacturing ...
Cached Medicine Technology:Lilly Health Channel Debuts on YouTube 2Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 2Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 3
(Date:9/4/2015)... , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... are prophetic details involving the Pope’s upcoming trip to the United States. , Yisrayl lays ... his role with the Vatican and society is. Yisrayl also provides the meaning of his ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... While bariatric ... to the best practices when preparing for a bariatric procedure, some patients have been ... Apart from the basic instructions typical for many types of surgery that should be ...
(Date:9/3/2015)... ... September 03, 2015 , ... The ... the Academy of Integrative Health & Medicine (AIHM) Interprofessional Fellowship in Integrative Health ... Low Dog, MD, an internationally renowned educator, physician and thought leader in integrative ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a non-profit organization ... Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for warm weather ... plans to bring 600 DriButts Diapers to rural areas of Haiti during a ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Spouse/Caregiver Scholarship applications are open for spring 2016. Scholarships are awarded two times ... Hope For The Warriors® is a national nonprofit dedicated to restoring a sense ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2
... , INDIANAPOLIS , Jan. 14 Eli ... it will provide donations of medicines and money for victims of ... . , "The current situation in Haiti is ... of the Lilly Foundation. "The significant number of casualties and widespread ...
... are failing to advise people with medical conditions that ... get behind the wheel, according to research from the ... School have found many healthcare professionals are failing to ... visual impairment if they are not fit to drive. ...
... they intended to cause harm, survey finds , THURSDAY, Jan. 14 ... percent of girls aged 12 to 17 were involved in serious ... , "These findings are alarming," SAMHSA administrator Pamela S. Hyde said ... reaching girls at risk and teaching them how to resolve problems ...
... The 2009 David ... children in New England and the Dominican Republic with access to the pediatric critical care ... ... Classic netted more than $225,000 for the David Ortiz Children’s Fund , providing children ...
... ... the devastating earthquake that struck Haiti yesterday. , ... (PRWEB) January 14, 2010 -- The Haiti ... the urgent need that the Haitian people have for medical care, housing, and other ...
... , Volunteers to honor Dr. King,s memory ... WASHINGTON , Jan. 14 American Red Cross and ... canvass neighborhoods in more than 40 cities across the country for ... year on January 18—the day Dr. King,s birthday is commemorated. ...
Cached Medicine News:Health News:Lilly Sends Relief to Haiti Earthquake Victims 2Health News:Health care professionals failing to tell patients they are not fit to drive 2Health News:David Ortiz Celebrity Golf Classic Nets More than $225,000 for Children in Need 2Health News:David Ortiz Celebrity Golf Classic Nets More than $225,000 for Children in Need 3Health News:Haiti Foundation Against Poverty Launches New Fundraising Drive to Help Victims of Earthquake 2Health News:American Red Cross and HOPE worldwide Partner for MLK Day of Service 2Health News:American Red Cross and HOPE worldwide Partner for MLK Day of Service 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: